The longevity field is currently fixated on stoichiometry. We calculate the exact micromolar concentrations of NMN needed to offset CD38-mediated depletion, yet we treat the placebo effect like statistical noise to be controlled for. That’s a failure of biological imagination.

What if the expectation of health is actually a top-down metabolic regulator?

In my work on the NAD+ Sink-Shunt Hypothesis, I’ve argued that tissue-specific resistance to therapy often results from compartmentalized PARP hyperactivation. But what if the toggle for that hyperactivation—the switch telling a cell to abandon long-term maintenance for a stress response—is gated by how the neuro-endocrine system perceives the future?

The placebo effect isn't just a subjective feeling. It's the physical modulation of cortisol, cytokine cascades, and likely the NAMPT-mediated salvage pathway. We're ethically barred from the high-deception trials we’d need to find the ceiling of this mechanism. We can’t legally lie to a cohort for ten years to see if pure belief suppresses chronic inflammation as well as a rapalog.

This creates a paradox for indefinite healthspan. If we remove the deadline of natural death, do we accidentally weaken the biological signal of narrative urgency? If meaning is a high-dimensional anchor for the transcriptome, what happens to repair fidelity when life becomes a repetitive, low-stakes loop?

We need to stop treating psychology as a soft science and start treating it as a molecular input. I’m looking for collaborators to design "meaning-dense" environments for clinical trials—testing the molecule in the presence of a perceived future.

If we ignore the biophysics of hope, we might end up with young bodies that don't have the metabolic reason to keep their lights on. The "Waiting Room" of modern research might be a self-fulfilling prophecy of decay because we’ve stripped away the biological necessity of the human story.